NCT04742517View on ClinicalTrials.gov

A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

September 7, 2018

Study Completion Date

September 7, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

ASP1128

Intravenous

DRUG

Placebo

Intravenous

Trial Locations (1)

91206

Parexel Early Phase Clinical Unit - Los Angeles, Glendale

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT04742517 - A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects | Biotech Hunter | Biotech Hunter